Manulife (Manufacturers Life Insurance)’s SOPHiA GENETICS SOPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-72,069
Closed -$323K 3008
2023
Q2
$323K Hold
72,069
﹤0.01% 2306
2023
Q1
$358K Hold
72,069
﹤0.01% 2208
2022
Q4
$162K Hold
72,069
﹤0.01% 2651
2022
Q3
$190K Hold
72,069
﹤0.01% 2612
2022
Q2
$267K Hold
72,069
﹤0.01% 2469
2022
Q1
$604K Buy
+72,069
New +$810K ﹤0.01% 2074

Other funds holding SOPH

Manulife (Manufacturers Life Insurance)'s SOPH Position: Q3 2023 in Review

Manulife (Manufacturers Life Insurance) sold out of SOPHiA GENETICS (SOPH) in Q3 2023, closing a stake of 72,069 shares — an estimated $323K sold.

Manulife (Manufacturers Life Insurance) first reported a position in SOPH in Q1 2022 and held it in 6 quarters. The position peaked at $604K in Q1 2022. 32 funds tracked by Wall St. Rank hold SOPH as of Q3 2023.

  • Manulife (Manufacturers Life Insurance) reported no remaining SOPHiA GENETICS position as of Q3 2023 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 72,069 SOPHiA GENETICS shares in Q3 2023, an estimated $323K.
  • Manulife (Manufacturers Life Insurance) first reported a position in SOPHiA GENETICS in Q1 2022 and held it in 6 quarters.
  • Manulife (Manufacturers Life Insurance)'s SOPHiA GENETICS position peaked at $604K in Q1 2022.
  • 32 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q3 2023.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2023, filed 15 Nov 2023.